Hamada H - Search Results

1

Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.

Cao X, Zhang W, Wang J, Zhang M, Huang X, Hamada H, Chen W. Cao X, et al. Among authors: hamada h. Immunology. 1999 Aug;97(4):616-25. doi: 10.1046/j.1365-2567.1999.00823.x. Immunology. 1999. PMID: 10457215 Free PMC article.

2

Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.

Cao X, Huang X, Ju DW, Zhang W, Hamada H, Wang J. Cao X, et al. Among authors: hamada h. Cancer Gene Ther. 2000 Feb;7(2):177-86. doi: 10.1038/sj.cgt.7700114. Cancer Gene Ther. 2000. PMID: 10770625

3

Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.

Cao X, Ju DW, Tao Q, Wang J, Wan T, Wang BM, Zhang W, Hamada H. Cao X, et al. Among authors: hamada h. Gene Ther. 1998 Aug;5(8):1130-6. doi: 10.1038/sj.gt.3300727. Gene Ther. 1998. PMID: 10326037

4

Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin.

Zhang W, He L, Yuan Z, Xie Z, Wang J, Hamada H, Cao X. Zhang W, et al. Among authors: hamada h. Hum Gene Ther. 1999 May 1;10(7):1151-61. doi: 10.1089/10430349950018148. Hum Gene Ther. 1999. PMID: 10340547

5

Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.

Cao X, Zhang W, He L, Xie Z, Ma S, Tao Q, Yu Y, Hamada H, Wang J. Cao X, et al. Among authors: hamada h. J Immunol. 1998 Dec 1;161(11):6238-44. J Immunol. 1998. PMID: 9834111

6

Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma.

Ju DW, Tao Q, Cheng DS, Zhang W, Zhang M, Hamada H, Cao X. Ju DW, et al. Among authors: hamada h. Gene Ther. 2000 Feb;7(4):329-38. doi: 10.1038/sj.gt.3301082. Gene Ther. 2000. PMID: 10694814

7

Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-gamma.

Lei H, Ju DW, Yu Y, Tao Q, Chen G, Gu S, Hamada H, Cao X. Lei H, et al. Among authors: hamada h. Gene Ther. 2000 Apr;7(8):707-13. doi: 10.1038/sj.gt.3301162. Gene Ther. 2000. PMID: 10800095

8

The potent antitumor effects of combined p16 gene and GM-CSF gene therapy through efficient induction of antitumor immunity.

Wang LH, Ju DW, Sun Y, Tao Q, Qian S, Mi J, Hamada H, Cao X. Wang LH, et al. Among authors: hamada h. J Cancer Res Clin Oncol. 2001 Feb;127(2):101-8. doi: 10.1007/s004320000187. J Cancer Res Clin Oncol. 2001. PMID: 11216910

9

Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100.

Xia DJ, Zhang WP, Zheng S, Wang J, Pan JP, Wang Q, Zhang LH, Hamada H, Cao X. Xia DJ, et al. Among authors: hamada h. Gene Ther. 2002 May;9(9):592-601. doi: 10.1038/sj.gt.3301694. Gene Ther. 2002. PMID: 11973635

10

Gene therapy for murine renal cell carcinoma using genetically engineered tumor cells to secrete interleukin-12.

Kasaoka Y, Nakamoto T, Wang J, Usui T, Hamada H. Kasaoka Y, et al. Among authors: hamada h. Hiroshima J Med Sci. 2000 Mar;49(1):29-35. Hiroshima J Med Sci. 2000. PMID: 10824454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,944 results

Search Page

Filters